EC-1456

· Endocyte

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EC-1456, covering 2019-02-07 to 2019-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors [Phase 1]